Coronavirus vaccine news, update: Deliveries to India could begin in late 2020, RDIF said, adding this was subject to the completion of trials and Sputnik-V’s registration by regulatory authorities in India. Last week Director-General of Indian Council of Medical Research (ICMR) Balram Bhargava told media, “Russia has been manufacturing vaccines for many years.
Russia’s sovereign wealth fund revealed that it would supply 100 million doses of Sputnik-V vaccine to Hyderabad-based Pharmaceutical firm Dr. Reddy’s Laboratories as Moscow was eyeing to speed up plans to distribute its shot abroad, as per the reports.
Also Read: Demand for lockdown again in Corona’s growing Europe
The deal for its Sputnik-V vaccine candidate comes after the Russian Direct Investment Fund (RDIF) reached agreements with Indian manufacturers to produce 300 million doses of the shot in India. The agreement brings the total number of doses Russia has so far announced that it will supply abroad to just over 200 million – half to Latin America and a half to India, as per a Reuters report. It will Deliveries to India could begin in late 2020.
They said and adding this was subject to the completion of trials and Sputnik-V’s registration by regulatory authorities in India. Phase III trials, involving at least 40,000 people, are ongoing in Russia. Initial results are expected in October or November, RDIF head Kirill Dmitriev has said, as per the Reuters report.
Last week Director-General of Indian Council of Medical Research (ICMR) Balram Bhargava told media, “Russia has been manufacturing vaccines for many years. Regarding the Russian Vaccine, a high-level committee of the Government of India is in dialogue with Russia. Once the Phase 3 trial is completed which Russia has started already, we should be able to go ahead.”
Latest News and updates, Follow and connect with us on Facebook, Twitter, and Linkedin
Get the latest updates directly on your mobile, save and send a message at +91-9899909957 on Whatsapp to start